Dimitra Anastasopoulou

Dimitra Anastasopoulou

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Nitric Oxide
Verified
Journal Article
Closed access
IAIakovos Armenis
Iakovos Armenis
VKVassiliki Kalotychou
Vassiliki Kalotychou
RTRevekka Tzanetea
Revekka Tzanetea
PKPanagoula Kollia
Panagoula Kollia
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
IRIoannis Rombos
Ioannis Rombos

16 May 2019 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
IAIakovos Armenis
Iakovos Armenis
VKVassiliki Kalotychou
Vassiliki Kalotychou
RTRevekka Tzanetea
Revekka Tzanetea
IMIoannis Moyssakis
Ioannis Moyssakis
DADimitra Anastasopoulou
Dimitra Anastasopoulou
IRIoannis Rombos
Ioannis Rombos

1 February 2017 in Data in Brief
Verified
Journal Article
Open access
IAIakovos Armenis
Iakovos Armenis
VKVassiliki Kalotychou
Vassiliki Kalotychou
RTRevekka Tzanetea
Revekka Tzanetea
PKPanagoula Kollia
Panagoula Kollia
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
IRIoannis Rombos
Ioannis Rombos
In this article, we present data on endothelial Nitric Oxide Synthase (eNOS) gene T786C and G894T polymorphisms in Greek steady-state Sickle Cell Disease patients in comparison to healthy controls. Moreover, eNOS mRNA levels were determined in peripheral blood samples from 18 patients and 9 controls. This article complements our recently published article named "Prognostic value of eNOS T786C and G894T polymorphisms in Sickle Cell Disease" (I. Armenis, V. Kalotychou, R. Tzanetea, Z. Kontogeorgiou, D. Anastasopoulou, M. Mantzourani, M. Samarkos, K. Pantos, K. Konstantopoulos, I. Rombos, 2016) [1].

29 June 2026 in Cells
Verified
Journal Article
Open access
PDF file
AFAikaterini Fyka
Aikaterini Fyka
DADimitra Anastasopoulou
Dimitra Anastasopoulou
MLMARINA LEIVADARA
MARINA LEIVADARA
ARISTIDES ELIOPOULOSARISTIDES ELIOPOULOS
ARISTIDES ELIOPOULOS
KGKalliopi Gkouskou
Kalliopi Gkouskou
Depressive disorders and obesity are highly comorbid conditions sharing genetic, metabolic, and immunological substrates. In a cross-sectional analysis of 53 participants across the obesity spectrum (lean n = 12; overweight n = 9; obese n = 32), a depression genetic risk score (d-GRS) correlated positively with BMI (ρ = 0.379, p = 0.005) and with serum CRP (ρ = 0.322, p = 0.031), consistent with the known genetic coarchitecture between depression and inflammatory traits. The d-GRS was tested against 116 flow-cytometry-derived immune parameters using Spearman rank correlation. The most consistent immune association at nominal significance (p < 0.05, uncorrected) involved the immunoregulatory CD56brightCD16− natural killer (NK) cell subset across two independent gate representations (ρ = 0.444, p = 0.004), remaining significant after sequential adjustment for BMI, sex, age, and physical activity (adjusted ρ range: 0.439–0.469), with no equivalent association for a genetically independent obesity GRS. In silico analysis of d-GRS SNP-tagged genes identified several with documented roles in NK cell trafficking, activation, and cytokine production, providing a putative mechanistic basis for this association. These findings nominate the CD56brightCD16− NK cell subset as a candidate immunological link between depression genetic susceptibility and neuroimmune mechanisms, warranting independent replication and functional characterisation in prospective cohorts.